Statement of Retraction: Exercise improves insulin and leptin sensitivity in hypothalamus of wistar rats. Diabetes 2006;55:2554-2561. DOI: 10.2337/db05-1622;Exercise improves insulin and leptin sensitivity in hypothalamus of wistar rats

Diabetes

Volumn 55, Issue 9, 2006, Pages 2554-2561

  Flores, Marcelo B S ^a   Fernandes, Maria Fernanda A ^a   Ropelle, Eduardo R ^a   Faria, Marcel C ^a   Ueno, Mirian ^a   Velloso, Lício A ^a   Saad, Mario J A ^a   Carvalheira, José B C ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

IL, interleukin; IRS, insulin receptor substrate; JAK, janus kinase; PI, phosphatidylinositol; STAT, signal transducer and activator of transcription

Indexed keywords

GLUCOSE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; INTERLEUKIN 6; JANUS KINASE; LEPTIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; STAT PROTEIN; INSULIN RECEPTOR SUBSTRATE 1 PROTEIN; INSULIN RECEPTOR SUBSTRATE-1 PROTEIN; JAK2 PROTEIN, RAT; JANUS KINASE 2; ONCOPROTEIN; PHOSPHOPROTEIN; PROTEIN TYROSINE KINASE; STAT3 PROTEIN; STAT3 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANOREXIA; ARTICLE; CONTROLLED STUDY; EXERCISE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HYPOTHALAMUS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; ANIMAL; BLOOD; DRUG EFFECT; EATING; ENZYME ACTIVATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; METABOLISM; PHYSIOLOGY; WISTAR RAT;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BLOOD GLUCOSE; EATING; ENZYME ACTIVATION; HYPOTHALAMUS; INJECTIONS, INTRAVENTRICULAR; INSULIN; INTERLEUKIN-6; JANUS KINASE 2; LEPTIN; MALE; PHOSPHOPROTEINS; PHYSICAL CONDITIONING, ANIMAL; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; RATS; RATS, WISTAR; STAT3 TRANSCRIPTION FACTOR;

EID: 33750591273     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db16-rt04b     Document Type: Erratum

References (53)

1. Richard D, Lachance P, Deshaies Y: Effects of exercise-rest cycles on energy balance in rats. Am J Physiol 256:R886-R891, 1989
2. Richard D, Rivest S: The role of exercise in thermogenesis and energy balance. Can J Physiol Pharmacol 67:402-409, 1989
3. Rivest S, Landry J, Richard D: Effect of exercise training on energy balance of orchidectomized rats. Am J Physiol 257:R550-R555, 1989
4. Wing RR, Hill JO: Successful weight loss maintenance. Annu Rev Nutr 21:323-341, 2001
5. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM: Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269:543-546, 1995
6. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P: Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269:546-549, 1995
7. Vaisse C, Halaas JL, Horvath CM, Darnell JE Jr, Stoffel M, Friedman JM: Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. Nat Genet 14:95-97, 1996
8. Ghilardi N, Ziegler S, Wiestner A, Stoffel R, Heim MH, Skoda RC: Defective STAT signaling by the leptin receptor in diabetic mice. Proc Natl Acad Sci U S A 93:6231-6235, 1996
9. Ghilardi N, Skoda RC: The leptin receptor activates janus kinase 2 and signals for proliferation in a factordependent cell line. Mol Endocrinol 11:393-399, 1997
10. Carvalheira JB, Siloto RM, Ignacchitti I, Brenelli SL, Carvalho CR, Leite A, Velloso LA, Gontijo JA, Saad MJ: Insulin modulates leptin-induced STAT3 activation in rat hypothalamus. FEBS Lett 500:119-124, 2001
11. Carvalheira JB, Ribeiro EB, Folli F, Velloso LA, Saad MJ: Interaction between leptin and insulin signaling pathways differentially affects JAK-STAT and PI 3-kinase-mediated signaling in rat liver. Biol Chem 384:151-159, 2003
12. Bjorbaek C, Uotani S, da Silva B, Flier JS: Divergent signaling capacities of the long and short isoforms of the leptin receptor. J Biol Chem 272:32686-32695, 1997
13. Kellerer M, Koch M, Metzinger E, Mushack J, Capp E, Haring HU: Leptin activates PI-3 kinase in C2C12 myotubes via janus kinase-2 (JAK-2) and insulin receptor substrate-2 (IRS-2) dependent pathways. Diabetologia 40:1358-1362, 1997
14. Carvalheira JB, Ribeiro EB, Araujo EP, Guimaraes RB, Telles MM, Torsoni M, Gontijo JA, Velloso LA, Saad MJ: Selective impairment of insulin signalling in the hypothalamus of obese Zucker rats. Diabetologia 46:1629-1640, 2003
15. Sun XJ, Rothenberg P, Kahn CR, Backer JM, Araki E, Wilden PA, Cahill DA, Goldstein BJ, White MF: Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 352:73-77, 1991
16. Lavan BE, Lane WS, Lienhard GE: The 60-kDa phosphotyrosine protein in insulin-treated adipocytes is a new member of the insulin receptor substrate family. J Biol Chem 272:11439-11443, 1997
17. Folli F, Saad MJ, Backer JM, Kahn CR: Insulin stimulation of phosphatidylinositol 3-kinase activity and association with insulin receptor substrate 1 in liver and muscle of the intact rat. J Biol Chem 267:22171-22177, 1992
18. Saad MJ, Folli F, Kahn JA, Kahn CR: Modulation of insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of dexamethasone-treated rats. J Clin Invest 92:2065-2072, 1993
19. Kuhne MR, Pawson T, Lienhard GE, Feng GS: The insulin receptor substrate 1 associates with the SH2-containing phosphotyrosine phosphatase Syp. J Biol Chem 268:11479-11481, 1993
20. Skolnik EY, Lee CH, Batzer A, Vicentini LM, Zhou M, Daly R, Myers MJ Jr, Backer JM, Ullrich A, White MF, et al.: The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Shc: implications for insulin control of ras signalling. EMBO J 12:1929-1936, 1993
21. Yamauchi K, Milarski KL, Saltiel AR, Pessin JE: Protein-tyrosine- phosphatase SHPTP2 is a required positive effector for insulin downstream signaling. Proc Natl Acad Sci U S A 92:664-668, 1995
22. Kobayashi T, Cohen P: Activation of serum- and glucocorticoid-regulated protein kinase by agonists that activate phosphatidylinositide 3-kinase is mediated by 3-phosphoinositide-dependent protein kinase-1 (PDK1) and PDK2. Biochem J 339:319-328, 1999
23. Pedersen BK, Hoffman-Goetz L: Exercise and the immune system: regulation, integration, and adaptation. Physiol Rev 80:1055-1081, 2000
24. Steensberg A, van Hall G, Osada T, Sacchetti M, Saltin B, Klarlund Pedersen B: Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. J Physiol 529:237-242, 2000
25. Penkowa M, Keller C, Keller P, Jauffred S, Pedersen BK: Immunohistochemical detection of interleukin-6 in human skeletal muscle fibers following exercise. FASEB J 17:2166-2168, 2003
26. Lyngso D, Simonsen L, Bulow J: Metabolic effects of interleukin-6 in human splanchnic and adipose tissue. J Physiol 543:379-386, 2002
27. Keller C, Keller P, Marshal S, Pedersen BK: IL-6 gene expression in human adipose tissue in response to exercise: effect of carbohydrate ingestion. J Physiol 550:927-931, 2003
28. Keller P, Keller C, Carey AL, Jauffred S, Fischer CP, Steensberg A, Pedersen BK: Interleukin-6 production by contracting human skeletal muscle: autocrine regulation by IL-6. Biochem Biophys Res Commun 310:550-554, 2003
29. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, et al.: Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1:1155-1161, 1995
30. Wallenius V, Wallenius K, Ahren B, Rudling M, Carlsten H, Dickson SL, Ohlsson C, Jansson JO: Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 8:75-79, 2002
31. Chibalin AV, Yu M, Ryder JW, Song XM, Galuska D, Krook A, Wallberg-Henriksson H, Zierath JR: Exerciseinduced changes in expression and activity of proteins involved in insulin signal transduction in skeletal muscle: differential effects on insulin-receptor substrates 1 and 2. Proc Natl Acad Sci U S A 97:38-43, 2000
32. Kimura M, Tateishi N, Shiota T, Yoshie F, Yamauchi H, Suzuki M, Shibasaki T: Long-term exercise downregulates leptin receptor mRNA in the arcuate nucleus. Neuroreport 15:713-716, 2004
33. Franke TF, Kaplan DR, Cantley LC, Toker A: Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate. Science 275:665-668, 1997
34. Niswender KD, Morton GJ, Stearns WH, Rhodes CJ, Myers MG Jr, Schwartz MW: Intracellular signalling: key enzyme in leptin-induced anorexia. Nature 413:794-795, 2001
35. Niswender KD, Morrison CD, Clegg DJ, Olson R, Baskin DG, Myers MG Jr, Seeley RJ, Schwartz MW: Insulin activation of phosphatidylinositol 3-kinase in the hypothalamic arcuate nucleus: a key mediator of insulin-induced anorexia. Diabetes 52:227-231, 2003
36. De Souza CT, Araujo EP, Bordin S, Ashimine R, Zollner RL, Boschero AC, Saad MJ, Velloso LA: Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology 146:4192-4199, 2005
37. Prada PO, Zecchin HG, Gasparetti AL, Torsoni MA, Ueno M, Hirata AE, Corezola do Amaral ME, Hoer NF, Boschero AC, Saad MJ: Western diet modulates insulin signaling, c-Jun N-terminal kinase activity, and insulin receptor substrate-1ser307 phosphorylation in a tissue-specific fashion. Endocrinology 146:1576-1587, 2005
38. Baumann H, Morella KK, White DW, Dembski M, Bailon PS, Kim H, Lai CF, Tartaglia LA: The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors. Proc Natl Acad Sci U S A 93:8374-8378, 1996
39. Bjorbaek C, El-Haschimi K, Frantz JD, Flier JS: The role of SOCS-3 in leptin signaling and leptin resistance. J Biol Chem 274:30059-30065, 1999
40. Stouthard JM, Romijn JA, Van der Poll T, Endert E, Klein S, Bakker PJ, Veenhof CH, Sauerwein HP: Endocrinologic and metabolic effects of interleukin-6 in humans. Am J Physiol 268:E813-E819, 1995
41. Rothwell NJ, Busbridge NJ, Lefeuvre RA, Hardwick AJ, Gauldie J, Hopkins SJ: Interleukin-6 is a centrally acting endogenous pyrogen in the rat. Can J Physiol Pharmacol 69:1465-1469, 1991
42. Tsigos C, Papanicolaou DA, Defensor R, Mitsiadis CS, Kyrou I, Chrousos GP: Dose effects of recombinant human interleukin-6 on pituitary hormone secretion and energy expenditure. Neuroendocrinology 66:54-62, 1997
43. Li G, Klein RL, Matheny M, King MA, Meyer EM, Scarpace PJ: Induction of uncoupling protein 1 by central interleukin-6 gene delivery is dependent on sympathetic innervation of brown adipose tissue and underlies one mechanism of body weight reduction in rats. Neuroscience 115:879-889, 2002
44. Nybo L, Nielsen B, Pedersen BK, Moller K, Secher NH: Interleukin-6 release from the human brain during prolonged exercise. J Physiol 542:991-995, 2002
45. Ostrowski K, Rohde T, Zacho M, Asp S, Pedersen BK: Evidence that interleukin-6 is produced in human skeletal muscle during prolonged running. J Physiol 508:949-953, 1998
46. Pedersen BK, Steensberg A, Schjerling P: Muscle-derived interleukin-6: possible biological effects. J Physiol 536:329-337, 2001
47. Febbraio MA, Pedersen BK: Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. FASEB J 16:1335-1347, 2002
48. Ohtani T, Ishihara K, Atsumi T, Nishida K, Kaneko Y, Miyata T, Itoh S, Narimatsu M, Maeda H, Fukada T, Itoh M, Okano H, Hibi M, Hirano T: Dissection of signaling cascades through gp130 in vivo: reciprocal roles for STAT3- and SHP2-mediated signals in immune responses. Immunity 12:95-105, 2000
49. Yamauchi T, Ueki K, Tobe K, Tamemoto H, Sekine N, Wada M, Honjo M, Takahashi M, Takahashi T, Hirai H, Tushima T, Akanuma Y, Fujita T, Komuro I, Yazaki Y, Kadowaki T: Tyrosine phosphorylation of the EGF receptor by the kinase Jak2 is induced by growth hormone. Nature 390:91-96, 1997
50. Hideshima T, Nakamura N, Chauhan D, Anderson KC: Biologic sequelae of interleukin-6 induced PI3-K/Akt signaling in multiple myeloma. Oncogene 20:5991-6000, 2001
51. Senn JJ, Klover PJ, Nowak IA, Mooney RA: Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 51:3391-3399, 2002
52. Rotter Sopasakis V, Larsson BM, Johansson A, Holmang A, Smith U: Short-term infusion of interleukin-6 does not induce insulin resistance in vivo or impair insulin signalling in rats. Diabetologia 47:1879-1887, 2004
53. Steensberg A, Fischer CP, Sacchetti M, Keller C, Osada T, Schjerling P, van Hall G, Febbraio MA, Pedersen BK: Acute interleukin-6 administration does not impair muscle glucose uptake or whole-body glucose disposal in healthy humans. J Physiol 548:631-638, 2003